A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
    

concept

Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazoniensis / W. Peters [and others].

Symposium on rifampicin in tuberculosis treatment : Held in Helsinki, Feb. 22-23, 1974. Program composed in cooperation with Mjolbolsta Hospital, with financial support of Ciba Pharmaceuticals / Chairman, Nils Riska.

Experimental and clinical studies on rifampicin in treatment of leprosy / [R.J.W. Rees, J.M.H. Pearson, M.F.R. Waters].

Galleries and Reading Room

Library

Shop

Café

Please note, you will be unable to request items in our collections or pre-register online from 04:00 – 07:00 on Tuesday 8 July due to essential maintenance work to our systems. Thank you for your understanding.

We're running paid user research studies to improve Wellcome Collection online

Rifampin

Catalogue

Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazoniensis / W. Peters [and others].

Symposium on rifampicin in tuberculosis treatment : Held in Helsinki, Feb. 22-23, 1974. Program composed in cooperation with Mjolbolsta Hospital, with financial support of Ciba Pharmaceuticals / Chairman, Nils Riska.

Experimental and clinical studies on rifampicin in treatment of leprosy / [R.J.W. Rees, J.M.H. Pearson, M.F.R. Waters].